ENTITY Rakuten Medical

Rakuten Medical

PulseAugur coverage of Rakuten Medical — every cluster mentioning Rakuten Medical across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

0

0 over 90d

TIER MIX · 90D

TOPICS

TIMELINE

2026-10-26 product_launch Rakuten Medical is advancing its novel photoimmunotherapy cancer treatment, Akalux, through U.S. clinical trials with a goal of FDA submission in 2028. source

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

RESEARCH · CL_321644 · Oct 26 · 05:10

Rakuten Medical advances 'lightsaber' cancer therapy toward US market

Rakuten Medical, a biotech subsidiary of Rakuten Group, is developing a novel photoimmunotherapy treatment for cancer that uses light to selectively destroy cancer cells. The company's technology, which combines a drug …